Balanced news tone
News Sentiment
PFE sentiment intelligence
Pfizer Inc. news scored across direct company coverage, industry context, sector read-through, source quality, and freshness.
Price is moving more forcefully than the current news tone suggests.
77/100 classification confidence.
directly relevant articles
high-authority source matches
+4.9% over one week, -0.7% over four weeks, trend inactive, and near fair-value range.
Pfizer (PFE) Stock Seems Fairly Priced As Oncology Approvals Build
Market Reaction
Price moving ahead of tone
Price is moving more forcefully than the current news tone suggests.
Sentiment Mix
Positive, neutral, negative
Relevance
Why the article matched
Sources
Coverage mix
Event Lens
What the news is about
Sentiment Trail
Score over time
News Tape
Relevant headlines
Pfizer (PFE) Stock Seems Fairly Priced As Oncology Approvals Build
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 21 Jul 2026 18:41
- Source
- simplywall.st
What to Watch in Pfizer's Non-Oncology Portfolio This Earnings Season
- Tone
- Neutral 50/100
- Event
- Earnings
- Published
- 21 Jul 2026 15:33
- Source
- The Globe and Mail
Is Trending Stock Pfizer Inc. (PFE) a Buy Now?
- Tone
- Positive 66/100
- Event
- Market update
- Published
- 20 Jul 2026 13:00
- Source
- Market source
Lobbying Update: $60,000 of PFIZER lobbying was just disclosed
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 19 Jul 2026 23:30
- Source
- Quiver Quantitative
Pfizer (NYSE:PFE) shares rise 3.6% on dividend strength as analyst forecasts remain unchanged
- Tone
- Neutral 50/100
- Event
- Analyst action
- Published
- 19 Jul 2026 16:36
- Source
- TechStock²
Pfizer (PFE) Stock Looks Fairly Priced With Pipeline Risks In View
- Tone
- Negative 34/100
- Event
- Market update
- Published
- 16 Jul 2026 17:12
- Source
- Market source
Pfizer Stock Below 50-Day and 200-Day SMA: Buy the Dip or Exit Now?
- Tone
- Positive 66/100
- Event
- Market update
- Published
- 16 Jul 2026 14:44
- Source
- Market source
Pfizer (NYSE:PFE) Faces New Patent Claim After $96 Billion in COVID Vaccine Revenue
- Tone
- Neutral 50/100
- Event
- Earnings
- Published
- 15 Jul 2026 21:47
- Source
- TechStock²
Pfizer (PFE) Stock Looks Fully Priced After Its 21% Slump
- Tone
- Negative 34/100
- Event
- Market update
- Published
- 14 Jul 2026 17:38
- Source
- simplywall.st
Pfizer (PFE) Stock Sinks As Market Gains: Here's Why
- Tone
- Positive 66/100
- Event
- Market update
- Published
- 06 Jul 2026 07:00
- Source
- Market source
Pfizer Inc. (PFE): A Top Dividend Stock to Buy According to Hedge Funds amid Ibrance FDA Milestone
- Tone
- Positive 66/100
- Event
- Capital return
- Published
- 05 Jul 2026 07:00
- Source
- Market source
Pfizer Stock’s Dividend Yield Sits at 7% Heading Into the Back Half of 2026
- Tone
- Neutral 50/100
- Event
- Capital return
- Published
- 03 Jul 2026 07:00
- Source
- TIKR.com
Pfizer's CEO Says His Company Has a "Very Big Balance Sheet" to Do Deals. Here's the Perfect Next Acquisition Target for the Pharma Giant.
- Tone
- Neutral 50/100
- Event
- Deals and strategy
- Published
- 02 Jul 2026 07:00
- Source
- Market source
Why Pfizer Could Prove to Be an Underrated GLP-1 Stock
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 30 Jun 2026 07:00
- Source
- The Motley Fool
Is Pfizer (PFE) Stock Undervalued Despite Mixed Oncology Progress?
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 30 Jun 2026 07:00
- Source
- Market source
Pfizer (PFE) Stock Declines While Market Improves: Some Information for Investors
- Tone
- Negative 34/100
- Event
- Market update
- Published
- 30 Jun 2026 07:00
- Source
- Market source
Is Pfizer Inc. (PFE) A Good Stock To Buy Now?
- Tone
- Positive 66/100
- Event
- Market update
- Published
- 29 Jun 2026 07:00
- Source
- Market source
Nike Hires Pfizer's Denton to Take Over for Departing CFO
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 24 Jun 2026 07:00
- Source
- Bloomberg.com
Pfizer Declares Third-Quarter 2026 Dividend
- Tone
- Neutral 50/100
- Event
- Capital return
- Published
- 24 Jun 2026 07:00
- Source
- Business Wire
Pfizer (PFE) Falls More Steeply Than Broader Market: What Investors Need to Know
- Tone
- Negative 34/100
- Event
- Market update
- Published
- 24 Jun 2026 07:00
- Source
- Market source
A Sizzling 6.7% Dividend Yield? 1 Under-the-Radar Reason I Am Holding Off on Pfizer Stock at $25
- Tone
- Neutral 50/100
- Event
- Capital return
- Published
- 11 Jun 2026 07:00
- Source
- 24/7 Wall St.
Healthcare Stocks: J&J & Pfizer 2026 Outlook Amid Tech Shifts - News and Statistics
- Tone
- Neutral 50/100
- Event
- Guidance
- Published
- 12 Apr 2026 07:00
- Source
- IndexBox
Lobbying Update: $2,870,000 of PFIZER INC. lobbying was just disclosed | PFE Stock News
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 12 Mar 2026 07:00
- Source
- Quiver Quantitative
Pfizer Stock (PFE) Today: 2026 Guidance Triggers Fresh Scrutiny—News, Forecasts, Analyst Targets and Dividend Outlook (Dec. 17, 2025)
- Tone
- Neutral 50/100
- Event
- Guidance
- Published
- 17 Dec 2025 08:00
- Source
- TechStock²
Pfizer Looks to Sell Stake in Pandemic Vaccine Partner BioNTech
- Tone
- Negative 34/100
- Event
- Deals and strategy
- Published
- 13 Nov 2025 08:00
- Source
- Bloomberg.com
Pfizer Reports Solid Third-Quarter 2025 Results; Raises and Narrows 2025 EPS Guidance
- Tone
- Positive 66/100
- Event
- Earnings
- Published
- 04 Nov 2025 08:00
- Source
- Business Wire
Pfizer spared pharma tariffs after offering drug discounts for TrumpRx website
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 30 Sep 2025 07:00
- Source
- Los Angeles Times
Pfizer Raises Profit View as Cost Cuts Offset Poor Sales Growth
- Tone
- Positive 82/100
- Event
- Earnings
- Published
- 05 Aug 2025 07:00
- Source
- Bloomberg.com
Pfizer Reports Strong Second-Quarter 2025 Results And Raises 2025 EPS Guidance
- Tone
- Positive 82/100
- Event
- Earnings
- Published
- 05 Aug 2025 07:00
- Source
- Business Wire
Pfizer shares rise 3% after upping profit forecast for 2025
- Tone
- Positive 66/100
- Event
- Earnings
- Published
- 05 Aug 2025 07:00
- Source
- Pharmaceutical Technology